万维提示：
1、投稿方式：在线投稿。
2、官网网址：https://onlinelibrary.wiley.com/journal/14401681
3、投稿网址：https://submission.wiley.com/journal/cep
4、官网邮箱：cepp@wiley.com（编辑部）
5、期刊刊期：月刊，一个月出版一期。
2021年5月7星期五
投稿须知
【官网信息】
Author Guidelines
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS
Editorial Commentaries (by invitation only)
• Word Limit: 2000 words
• Abstract: No abstract
• References: Up to 10
• Description: Proposals for Editorial Commentaries may be submitted for consideration. An outline of the proposed Editorial Commentary should be submitted in the first instance rather than the full text.
Reviews
• Word limit: 6000 words, including Title Page, Abstract, Text, References and Tables
• Abstract: 250 words maximum
• References: Up to 120 Figures/tables: Maximum 8.
• Description: Reviews are comprehensive analyses of specific topics. Proposals for reviews may be submitted with an outline of the proposed paper, the abstract and the author’s publication list for initial consideration. Both solicited and unsolicited review articles will undergo peer review prior to acceptance.
Research highlights (by invitation only)
• Word Limit: 3000 words, including Title Page, Abstract, Text, References and Tables
• Abstract: 250 words maximum
• References: Up to 80
• Figures/Tables: Maximum 4
• Description: Research Highlights are invited on a particular topic and an editor is appointed to oversee the peer review process. The manuscripts are presented in the form of a mini-review. Original data may be included, but if so, sufficient detail on methods must be provided so that proper peer review can be accomplished. Further instructions are provided upon invitation.
Original Articles
• Word limit: 6000 words, including Title Page, Abstract, Text, References and Tables Abstract: 250 words maximum
• References: Up to 60
• Figures/tables: Maximum 8
• Description: Full-length reports of current research in any of the fields covered by the title Clinical and Experimental Pharmacology and Physiology, interpreted in the broadest sense. The text should be arranged as follows: Abstract, Introduction, Results, Discussion, Methods, Acknowledgements, References. Supporting information should be provided in a separate file.
New pathways: Transferred Peer Review. Please read the section 'New Pathways: Transferred Peer Review' above for information on submitting original articles along with reviews from selected other journals. More details on the CEPP New Pathways program can be found here.
Technical Paper
• Word Limit: 6000 words, including Title Page, Abstract, Text, References and Tables
• Abstract: 250 words maximum
• References: Up to 60
• Figures/tables: Maximum 8
• Description: Technical Papers should be based mainly on the presentation of new techniques, or the testing or critique of existing techniques. These should be structured like Original Articles.
Rapid Communications
• Word limit: 3000 words (excluding references)
• Abstract: maximum 250 words
• Figures/ tables: 4 maximum
• References: 60 maximum
• Description: Rapid Communications report most important new findings and are given priority by the Editorial Office. The text should include Abstract, Introduction, Results, Discussion, Methods, Acknowledgements and References. Authors should indicate the reasons for Rapid publication.
Letters to the Editor
• Word limit: 1200 words
• Abstract: 120 words
• References: Up to 30
• Figures/ tables: 2 maximum
• Description: Letters may be submitted to the Editor on any topic of short cutting edge research. Comments on papers recently published in CEPP will be welcomed. They should include a brief summary and key words, but no subheadings. Name, postal address, telephone, facsimile numbers and email addresses of the corresponding author should be given on the title page.
Letters to the Editor are not subjected to external peer review, but will be reviewed by at least one editor or editorial board member. Submissions may be edited for length, grammatical correctness, and journal style. Authors will be asked to approve editorial changes that alter the substance or tone of a letter or response. Letters that offer perspective on content already published in the Journal can use an arbitrary title, but a response from authors must cite the title of the first Letter: e.g. Response to [title of Letter]. This ensures that readers can track the line of discussion.
4. PREPARING THE SUBMISSION
Manuscript Format and Style
Manuscripts should follow the style of the Vancouver agreement detailed in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, as presented in JAMA 1997; 277: 927-34.
Spelling. The journal uses UK spelling and authors should follow the latest edition of the Oxford Concise English Dictionary.
Footnotes. Footnotes arising from the text must not be used.
Standard abbreviations. These should be used sparingly. They should be defined in the Summary and on the first mention in the text. In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader.
Units of measurement.As far as possible, these should conform to the SI conventions, with the notable exception that blood pressures should be given in mmHg. It is strongly recommended that contributors consult the booklet Units, Symbols and Abbreviations: A Guide for Biological and Medical Editors and Authors (Ed. D. N. Baron), 1988, The Royal Society of Medicine Services, London. The recommendations outlined therein will be followed.
Methods of statistical analysis
The journal recommends that investigators seek the advice of a professional biostatistician in the design stage of their study, as well as during the stage of actual data analysis. Statistical methods used should be identified, with appropriate citation of statistical texts or articles that describe their use. Reasons for choosing particular methods of analysis, and for the number of experimental units, should be stated. The name and source of commercial statistical computer packages used should be identified. The statistical section should contain sufficient detail for the reader to have a clear idea about how the analysis was performed. The level of statistical significance (alpha) should be defined and it should be stated explicitly whether this refers to one- or two-sided probability. Nevertheless, exact P values should be given to a sensible number of significant figures (e.g. P = 0.01 rather than P = 0.0058). The risk of type 1 error (a false positive inference) should always be controlled. This requires the use of global statistical tests of significance where possible, particularly in experimental designs that involve repeated measurements in the same experimental units (humans, animals, tissues or cells). Multiple comparisons within a single experiment should only be made when this is absolutely necessary and, if so, P values should be conservatively corrected to control the risk of type 1 error. Two techniques that provide excellent control of the type 1 error rate are the 'false discovery rate' procedure (Curran-Everett D, Benos DJ. Guidelines for reporting statistics in journals published by the American Physiological Society. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004; 287: R247-9) and the Ryan-Holm stepdown Bonferroni procedure (Ludbrook J. Multiple comparison procedures updated. Clin. Exp. Pharmacol. Physiol. 1998; 25: 1032-7). Confidence intervals may be used in addition to P values.
Data should be expressed as mean (SD) when the intention is to indicate the degree of variability of the data around the mean value, and as mean ± SEM when the intention is to estimate the population mean from the sample data. In either case, the numbers of observations (n) should be stipulated. This allows the reader to calculate SD from SEM and vice versa. (For further reading, see Ludbrook J. Comments on journal guidelines for reporting statistics. Clin. Exp. Pharmacol. Physiol. 2005; 32: 324-6 (Letter). Detailed guidelines on the use and presentation of statistics in Clin. Exp. Pharmacol. Physiol. can be found online.
Chemical substances
These must be properly identified. Except for standard laboratory chemicals, the source of supply must be given. Drug nomenclature should follow the rules of the International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification, published in various articles in Pharmacological Reviews. Proprietary names should be avoided unless the paper is concerned with a specific formulated product, in which case the nature of the formulation should be stated. Isotopically labelled chemicals should be identified by the atomic number and symbol of the isotope, its location in the molecule and the specific activity in standard (SI) units.
Receptors
For receptor types, nomenclature should also follow the conventions established by the IUPHAR Committee on Receptor Nomenclature and Drug Classification (International Union of Basic and Clinical Pharmacology), which are published in Pharmacological Reviews.
Parts of the Manuscript
Submissions via the new Research Exchange portal can be uploaded either as a single document (containing the main text, tables and figures), or with figures and tables provided as separate files. Should your manuscript reach revision stage, figures and tables must be provided as separate files. The main manuscript file can be submitted in Microsoft Word (.doc or .docx) formats.
Manuscripts should be presented in the following order: (i) Title Page, (ii) Abstract and keywords, (iii) Introduction, (iv) Results, (v) Discussion, (vi) Methods, (vii) Acknowledgements (including disclosure), (viii) References, (ix) tables (each table complete with title and footnotes), (x) figure legends and (xi) figure. Supporting Information should be supplied as a supplementary file.
The first page of the manuscript should contain the following information:
Title: The title should be as informative as possible but should avoid over-detailed information about the experimental procedures. Titles should not exceed 250 characters (including spaces).
Family name for each author, preceded by initial(s) or given name(s): That part of each family name which is to appear in indexes must be underlined.
Laboratory or Institute: The official name (in English) of each place in which the work reported in the manuscript was carried out should be given, together with the larger organization (if applicable), city, state (if applicable) and country.
Short title: This will be used as a running heading in the printed text; it must not exceed a total of 45 characters (including spaces) and should be as informative as possible within this limit. Abbreviations should be avoided if possible.
Author for correspondence: The name and full postal address, facsimile, telephone and email details of the corresponding author must be provided and clearly identified. All correspondence regarding the manuscripts, proofs and requests for reprints will be sent to this author, using the contact details provided.
Present addresses of authors: Should the addresses of other authors differ from that of the author for correspondence, this information should be provided and will be published.
Abstract and keywords
Abstract. This should commence on page two and consist of a continuous paragraph, describing the aim of the study, what was done, the main findings and the conclusions reached. A limit of 250 words applies to article abstracts, and 120 for Letters to the Editor.
Key words: These are required for indexing the content of the paper, and should, if possible, be selected from the US National Library of Medicine's Medical Subject Headings (MeSH) browser list. A maximum of 10 words or phrases should be sufficient. Key words should be arranged in alphabetical order.
References: Up to 60
Figures/tables: Maximum 8
Description: Technical Papers should be based mainly on the presentation of new techniques, or the testing or critique of existing techniques. These should be structured like Original Articles.
Introduction
This section should commence on a new page and contain a concise statement of the reason for doing the work, and should not contain a major statement about either the findings or the conclusions.
Results
The findings should be presented clearly with adequate reference to figures and tables. The text of Results and the information contained in figures and tables should complement one another; repetitive presentation of the same data should be avoided. Material appropriate to Discussion should not be included in Results. However, brief comments on minor points are acceptable if they help to consolidate the new information being presented or if they assist the reader to follow the progression of ideas in moving from one set of data to another.
Discussion
This should not be a mere reiteration of the Results. It should deal with the relationship of the new information given in Results to the corpus of knowledge in that field, and should be pertinent to the data presented. The main conclusions should be incorporated in the final paragraph.
……
